Takeda Pharmaceutical Company Limited TKPHF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 70.24% | 130.26% | -449.17% | 940.31% | -109.30% |
| Total Depreciation and Amortization | 1.00% | 32.36% | -37.50% | -1.38% | -0.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -295.33% | 15.39% | -76.65% | -38.18% | 415.98% |
| Change in Net Operating Assets | 106.45% | -171.25% | 726.75% | -271.56% | 163.75% |
| Cash from Operations | 138.75% | 68.66% | -80.39% | -5.57% | 71.95% |
| Capital Expenditure | 16.83% | -14.32% | -9.37% | 0.64% | 18.04% |
| Sale of Property, Plant, and Equipment | -66.83% | 1,899.22% | 253.65% | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 17.49% | 1,900.88% | -84.02% | 755.56% | -98.82% |
| Other Investing Activities | 124.20% | -266.21% | 93.73% | -2,081.83% | 60.78% |
| Cash from Investing | 75.94% | -48.89% | 75.20% | -356.85% | -42.02% |
| Total Debt Issued | -- | -- | -- | -100.00% | 86.60% |
| Total Debt Repaid | -2,115.13% | 86.82% | -766.02% | 96.77% | -66.70% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 94.84% | -1,582.85% | 94.21% | -1,522.96% | 94.08% |
| Other Financing Activities | -197.19% | 58.41% | -28.52% | 15.65% | -120.53% |
| Cash from Financing | -72.70% | -129.23% | 60.45% | -1,437.05% | 94.54% |
| Foreign Exchange rate Adjustments | -330.42% | 469.55% | -95.19% | 60.71% | 637.51% |
| Miscellaneous Cash Flow Adjustments | -200.00% | 198.44% | -- | -- | -- |
| Net Change in Cash | 68.29% | -120.52% | -121.52% | -107.66% | 1,024.77% |